epocrates logo
epocrates logo
epocrates logo
  • 0

Herbs & Supplements

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

close

 

Select a medication above to begin.

petit poivre

chasteberry (Vitex agnus-castus)

Sections:

  • Entire Monograph
  • Reported Uses
  • Reported Doses
  • Cautions
  • Drug Interactions
  • Adverse Reactions
  • Synonyms
  • Other Info
  • Add to Interaction Check

Entire Monograph

Reported Uses

  • NOTE: see Herb & Supplement Effectiveness Rating Definitions table
  • acne [Insufficient Evidence]
  • aging skin [Insufficient Evidence]
  • amenorrhea [Insufficient Evidence]
  • anxiety [Insufficient Evidence]
  • BPH [Insufficient Evidence]
  • dementia [Insufficient Evidence]
  • dysmenorrhea [Insufficient Evidence]
  • fibrocystic breast disease [Insufficient Evidence]
  • fracture [Possibly Ineffective]
  • hyperprolactinemia [Insufficient Evidence]
  • infertility in patients of childbearing potential [Insufficient Evidence]
  • insect repellent [Insufficient Evidence]
  • insomnia [Insufficient Evidence]
  • lactation stimulation [Insufficient Evidence]
  • mastalgia [Possibly Effective]
  • menopausal symptoms [Insufficient Evidence]
  • heavy menstrual bleeding [Insufficient Evidence]
  • migraine [Insufficient Evidence]
  • polycystic ovary syndrome [Insufficient Evidence]
  • premenstrual dysphoric disorder [Insufficient Evidence]
  • premenstrual syndrome [Possibly Effective]
  • rheumatoid arthritis [Insufficient Evidence]
  • sexual dysfunction [Insufficient Evidence]

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies with variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

aging skin

[Insufficient Evidence]
Dose: 400 mg PO qd

insect repellent

[Insufficient Evidence]
Dose: apply extract topically

mastalgia

[Possibly Effective]
Dose: 3.2-40 mg extract PO qd

menopausal symptoms

[Insufficient Evidence]
Dose: 15 mg extract PO bid; Alt: 1000 mg dried fruit PO qd; 400 mg PO qd

premenstrual dysphoric disorder

[Insufficient Evidence]
Dose: 20-40 mg extract PO qd

premenstrual syndrome

[Possibly Effective]
Dose: 4-40 mg extract PO qd; Alt: 3.2-6 mg extract PO bid; 3.5-4.2 mg PO qd on days 16-35 of menstrual cycle; 40 drops extract PO qd

sexual dysfunction

[Insufficient Evidence]
Dose: 3.2-4.8 mg extract PO qd; Alt: 40 drops extract PO qd

Copyright © 2026. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.

Select a medication above to begin.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information